Industry: Drug Manufacturers #pharma #licensing

Posted On Jul 26 2017 by

#drug manufacturers # Drug Manufacturers – Major The pharmaceutical industry consists of companies that research, develop, market, and distribute drugs for nearly every therapeutic need. Drug sales from the 65 largest pharmaceuticals totaled $606 billion in 2007 and continues to grow. [1] Commercial drug companies are driven by research and patent protection. Developing a drug requires an enormous amount of investment in technology, materials, and time, and can be a risky venture for the company. However, after a new drug is successfully developed, thoroughly tested, and patented, it may be potentially very lucrative, especially if it addresses a common health …


Drug Channels: 2013 Pharmacy Market Share for Specialty Drugs – and the Biggest Players #big

Posted On Jul 25 2017 by

#pharmaceutical companies market share # Our research shows a booming market: In 2013, retail, mail, and specialty pharmacies dispensed about $63 billion in specialty pharmaceuticals. Specialty drugs accounted for 22% of total pharmacy industry revenues. Three companies Express Scripts, CVS Caremark, and Walgreens accounted for 63% of revenues from pharmacy-dispensed specialty drugs. The next three largest players had a combined share of about 5%. Read on for our market share estimates for the top players, observations on the market’s structure, and details of my panel discussion with specialty pharmacy leaders at next week s sPCMA Business Forum . THE NOMINEES …


Drug Interactions Checker – Check Your Brand and Generic Drugs #lexicon #pharma

Posted On Jul 25 2017 by

#pharmaceutical drugs # Interaction is unlikely, minor, or nonsignificant Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect. Drug Interactions Drug interactions overview Whenever two or more drugs are being taken, there is a chance that …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #biggest

Posted On Jul 25 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Outsourced Pharma, Contract Pharmaceutical, CRO, CMO, Pharmaceutical Drug Development Services #global #pharm

Posted On Jul 24 2017 by

#cro pharma # I didn t quite buy into the DCAT announcement regarding its departure from the Waldorf Astoria, the long-time central location for DCAT Week in New York City each spring. Call me cynical a degree in public relations can do that but I just couldn t believe checking out of the Waldorf would be as easy as it sounded. I took this cynicism directly to Margaret Timony, Executive Director of the Drug, Chemical Associated Technologies Association. At the turn of the 21st century, a rare, Houston-based biotech, busy pursuing the development of its own drugs and IP, discovers …


11 Biggest Generic Drug Companies in the World – Insider Monkey #beta #pharma

Posted On Jul 24 2017 by

#generic drug companies # Dear Valued Visitor, We have noticed that you are using an ad blocker software. Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login . We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a …


CDRD-Canada – s national drug development – commercialization engine #par #pharma

Posted On Jul 24 2017 by

#drug research companies # On June 3rd, CDRD hosted our global partners including the US National Institutes of Health (NIH), the European Infrastructure for Translational Medicine (EATRIS), Therapeutic Innovation Australia and MRC Technology (UK). On May 26th, CDRD hosted a partnership appreciation lunch and open house. Thank you to everyone for your ongoing support! Quark Venture has made a significant seed investment in Sitka Biopharma – a critical value-creating event that will enable Sitka to advance their lead compound for the treatment of bladder cancer into clinical trials. In total, over one-third of all the life science companies included in …


Future of Pharmaceutical Industry – pharma innovation gaps, patent expiry, empty drug pipelines #world-pharma.org

Posted On Jul 22 2017 by

#future of pharmaceutical industry # The pharmaceutical industry is facing huge challenges – described in video above and in powerpoint slides below. Notes on content: Over the last five years there has been serious lack of innovation in pharma companies and product pipelines have been emptying. It takes up to 15 years and $1 billion in investment to bring a single new treatment to market, after which there may be as little as a decade left before patents expire. But before that happens there may be serious threats to the pharmaceutical industry from generic manufacturers. And at any point in …


Teva Buys Drug Rival, Barr, for $ Billion #drug #chemistry

Posted On Jul 22 2017 by

#barr pharma # The New York Times Teva Buys Drug Rival, Barr, for $7.46 Billion July 19, 2008 Teva Pharmaceutical Industries said Friday that it would buy a rival generic drug maker, Barr Pharmaceuticals, for $7.46 billion to expand in both the United States and Europe. The deal is the latest in a wave of consolidation in the generic-drug sector that some analysts suspect will result in only a handful of major global players. Teva, the world’s largest generic drug company, plans to buy Barr for $66.50 a share in cash and stock. The price represents a 42 percent premium …


How A Big Drug Company Inadvertently Got Americans Hooked On Heroin #mitsubishi #tanabe #pharma

Posted On Jul 22 2017 by

#perdue pharma # How A Big Drug Company Inadvertently Got Americans Hooked On Heroin When she was 18, Arielle would come home every day and embark on what she calls an “Easter egg hunt.” She wasn’t looking for candy. Arielle was hunting behind stairwells and inside closets in her suburban Long Island home for the OxyContin bottles her cousin brought home from work at a pharmacy and was hiding from her mother around the house. “I found them one day, and I wanted to try them because all of my friends were already hooked,” said Arielle, who asked that her …